Skip to search formSkip to main contentSkip to account menu

XPro1595

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

XENP 1595

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Systemic inhibition of soluble TNF with XPro1595 exacerbates a post-spinal cord injury depressive phenotype in female rats.
Spinal cord injury is associated with a 3-fold risk of major depressive disorder compared to the general population. Current… 
2019
2019
Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective – a Commentary
ABSTRACT Introduction: The importance of excessive cerebral tumor necrosis factor (TNF) concentrations as one of the central… 
2017
2017
Topical administration of TNF-inhibitor XPro1595 decreases infarct volume after experimental stroke
2014
2014
Central but not peripheral administration of XPro1595 is therapeutic following moderate spinal cord injury in mice
2011
2011
The Dominant-Negative Soluble TNF Inhibitor XPro1595 Can Suppress Experimental Autoimmune Uveitis
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)